Le Prix international Inserm 2025 sera décerné au professeur Charles Swanton, clinicien-chercheur de renommée mondiale, pour ses travaux pionniers sur les mécanismes inflammatoires liant vieillissement, pollution et cancer du poumon.
Cette cérémonie s’inscrit dans le cadre d’une demi-journée de rencontres scientifiques qui mettra en lumière la recherche Inserm et les collaborations internationales auxquelles l’Institut participe dans trois domaines : la santé publique, la résistance aux antimicrobiens et la recherche sur le cancer.
Les interventions des invités seront suivies par une présentation des initiatives de l’Inserm pour la collaboration internationale. Plusieurs accords seront signés :
- un projet Tremplin international,
- un projet de recherche internationale (PRI),
- un Joint lab,
- un accord franco-britannique sur les biomarqueurs en santé mentale.
La journée se terminera par un moment convivial.
S’inscrire
Pour participer à cet évènement, ou pour plus d’informations écrire à :
international.prize.2025@inserm.fr
Informations pratiques
- Lieu : Résidence de France, 11 Kensington Palace Gardens, Londres (présentiel uniquement, nombre de places limité)
- Date : 27 octobre
- Horaire : à partir de 13h30
Programme
13:30 – Opening Session
Didier Samuel, Chairman and CEO of Inserm
13:40 – Building high-quality cohorts : International Challenges and Opportunities
Chair : Robert Barouki, Paris-Cité University, APHP, Director of the Thematic Institute for Public Health at Inserm
Speakers :
- Naomi Allen, Chief Scientist for UK Biobank and Professor, Nuffield Department of Population Health, University of Oxford – “How UK Biobank is transforming future health”
- Paul Elliott, Director of MRC Centre for Environment and Health – “The REal-time Assessment of Community Transmission (REACT) Cohort of over 3 million people across England”
- Archana Singh-Manoux, Research Director at Inserm, U1153 CRESS – “The Whitehall II study : from social determinants to ageing”
- Antoine Duclos, Professor at Paris-Cité University, Inserm U1153 CRESS – “The Constances cohort : one of the largest epidemiological studies in France”
- Amaria Baghdadli, Montpellier University, Inserm U1018 CESP, Director of the Montpellier Center of Excellence for Autism and Neurodevelopmental Disorders – “MARIANNE Cohort – Understanding Developmental Trajectories in Neurodevelopmental Disorders, from Pregnancy to Childhood”
- Barbara Heude, Research Director at Inserm, U1153 CRESS – “FiLOMENE – A new large couple-child cohort to study the relations between the exposome and children’s health”
14:50 – Showcasing the Inserm – UK collaboration in cancer research
Chair : Bruno Quesnel, Professor at Lille University & CHU de Lille, Director of the Research and Innovation Division at the French National Cancer Institute (INCa) and of the Thematic Institute for Cancer at Inserm
Speakers :
- Sophie Postel Vinay, Research Director at Gustave Roussy Institute, Inserm U981 – Title to be announced
- Thomas Mercher, Research Director at Inserm, U1170 – “Pediatric myeloid leukemia : models, molecular bases and clinical implications”
- Dominique Bonnet, Hematopoietic Stem Cell Laboratory Team Leader, The Francis Crick Institute – “The opposite role of clonal hematopoietic mutation on stemness and immunity”
16:00 – Tackling antimicrobial resistance
Chair : Yazdan Yazdanpanah, Director of the Thematic Institute for Immunology and Infectious Diseases at Inserm, Director ANRS EID & Jean-Yves Madec, AMR Program Coordinator, Inserm/ANRS-EID
Speakers :
- Marie-Cécile Ploy, Professor at Limoges University & CHU, Director of Inserm U1092 RESINFIT – “The global landscape of AMR”
- Till Bachmann, Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, University of Edinburgh – “The opposite role of clonal hematopoietic mutation on stemness and immunity”
- Alison Holmes, Director of the Fleming Initiative and the Centre for Antimicrobial Optimisation (CAMO), Imperial College London – “Optimising antimicrobial use”
17:00 – Closing Remarks
Didier Samuel, Chairman and CEO of Inserm
17:25 – Signatures of French-UK collaborations
- First step – CILIAFISH : Marine Laporte, Inserm – Julien Vermot, ICL
- First step – AntiTOL : Julien Vaubourgeix, Inserm – Eachan Johnson, Francis Crick Institute
- International Research Program – ReSync : Ouldali Naïm & Léa Lenglart, Inserm – Ruud Nijman, ICL
- Joint lab TargetDiscov : Sophie Postel Vinay, Inserm – Sergio Quezada, UCL
- Biomarkers Mental Health : Marion Leboyer, Inserm – Rachel Upthegrove, Oxford University
18:05 – Closing Remarks
Hélène Duchêne, Ambassador of France in the United Kingdom
18:15 – Inserm International Award and Keynote
Charles Swanton, laureate of the Inserm International Prize – “Myeloid Mayhem : Inflammatory Pathways Linking Ageing, Pollution, and Lung Cancer”
19:00 – Cocktail
